|
FAM84B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.336000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.173000E-01 |
| Normal-vs-Stage2 |
2.681200E-01 |
| Normal-vs-Stage3 |
6.539800E-01 |
| Normal-vs-Stage4 |
6.519800E-01 |
| Stage1-vs-Stage2 |
5.590200E-01 |
| Stage1-vs-Stage3 |
3.759600E-01 |
| Stage1-vs-Stage4 |
4.516400E-01 |
| Stage2-vs-Stage3 |
2.969800E-01 |
| Stage2-vs-Stage4 |
2.911600E-01 |
| Stage3-vs-Stage4 |
9.100200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.781000E-01 |
| Normal-vs-AfricanAmerican |
8.908800E-01 |
| Normal-vs-Asian |
7.162400E-02 |
| Caucasian-vs-AfricanAmerican |
9.896400E-01 |
| Caucasian-vs-Asian |
3.530400E-01 |
| AfricanAmerican-vs-Asian |
2.755200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.701600E-01 |
| Normal-vs-Female |
2.689800E-01 |
| Male-vs-Female |
7.246400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.802200E-01 |
| Normal-vs-Extreme_Weight |
1.574440E-01 |
| Normal-vs-Obese |
6.350600E-01 |
| Normal-vs-Extreme_Obese |
6.404400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.627000E-01 |
| Normal_Weight-vs-Obese |
7.158400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.977800E-01 |
| Extreme_Weight-vs-Obese |
1.325610E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.276800E-01 |
| Obese-vs-Extreme_Obese |
7.907600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.332000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.619200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.936400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.595970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.921200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.339220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.292100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.379150E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.552000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.989400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.884000E-01 |
| Normal-VS-Type2 PRCC |
5.083600E-02 |
| Normal-VS-KIRP CIMP |
1.341030E-01 |
| Normal-VS-Unclassified PRCC |
9.462200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.104000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.575180E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.883600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.226300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.521040E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.496390E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.045640E-02 |
| Normal-vs-N1 |
1.222220E-01 |
| Normal-vs-N2 |
6.058200E-01 |
| N0-vs-N1 |
1.029930E-02 |
| N0-vs-N2 |
9.986000E-01 |
| N1-vs-N2 |
2.730400E-01 |
|
|
